To determine the transforming activity of TLK2, we selected the MCF10A benign breast epithelial cell line and the TLK2-low luminal breast cancer cell line T47D (ER+/Her2−) for the engineering of TLK2 ectopic OE models. Here, ESR1 is linked to breast carcinoma.